These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 8717397)

  • 1. Immunity and vaccine development in Pasteurella multocida infections.
    Adler B; Chancellor R; Homchampa P; Hunt M; Ruffolo C; Strugnell R; Wapling D
    J Biotechnol; 1996 Jan; 44(1-3):139-44. PubMed ID: 8717397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross protective immunity conferred by a marker-free aroA mutant of Pasteurella multocida.
    Homchampa P; Strugnell RA; Adler B
    Vaccine; 1997 Feb; 15(2):203-8. PubMed ID: 9066039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of two live Pasteurella multocida aro-A mutant vaccines in chickens.
    Scott PC; Markham JF; Whithear KG
    Avian Dis; 1999; 43(1):83-8. PubMed ID: 10216763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective immunity conferred by recombinant Pasteurella multocida lipoprotein E (PlpE).
    Wu JR; Shien JH; Shieh HK; Chen CF; Chang PC
    Vaccine; 2007 May; 25(21):4140-8. PubMed ID: 17449151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-protection and antigen expression by chicken embryo-grown Pasteurella multocida in chickens.
    Ibrahim RS; Sawada T; Shahata M; Ibrahim A
    J Comp Pathol; 2000 Nov; 123(4):278-84. PubMed ID: 11041997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of vaccination of calves against hemorrhagic septicemia with a live aroA derivative of Pasteurella multocida B:2 by two different routes of administration.
    Hodgson JC; Finucane A; Dagleish MP; Ataei S; Parton R; Coote JG
    Infect Immun; 2005 Mar; 73(3):1475-81. PubMed ID: 15731045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of chickens by ribosomal vaccines from Pasteurella multocida: dependence on homologous lipopolysaccharide.
    Phillips M; Rimler RB
    Am J Vet Res; 1984 Sep; 45(9):1785-9. PubMed ID: 6208828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outer membrane protein of Pasteurella multocida serotype B:2 is immunogenic and antiphagocytic.
    Srivastava SK
    Indian J Exp Biol; 1998 May; 36(5):530-2. PubMed ID: 9717471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective immunity conferred by attenuated aroA derivatives of Pasteurella multocida B:2 strains in a mouse model of hemorrhagic septicemia.
    Tabatabaei M; Liu Z; Finucane A; Parton R; Coote J
    Infect Immun; 2002 Jul; 70(7):3355-62. PubMed ID: 12065473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive cross-protection provided by antisera directed against in-vivo-expressed antigens of Pasteurella multocida.
    Wang C; Glisson JR
    Avian Dis; 1994; 38(3):506-14. PubMed ID: 7832703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic reactivity of a lipopolysaccharide-protein complex of type A Pasteurella multocida in mice.
    Ryu HI; Kim CJ
    J Vet Sci; 2000 Dec; 1(2):87-95. PubMed ID: 14614303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outer membrane protein H for protective immunity against Pasteurella multocida.
    Lee J; Kim YB; Kwon M
    J Microbiol; 2007 Apr; 45(2):179-84. PubMed ID: 17483806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning, expression and protective capacity of 37 kDa outer membrane protein gene (ompH) of Pasteurella multocida serotype B:2.
    Tan HY; Nagoor NH; Sekaran SD
    Trop Biomed; 2010 Dec; 27(3):430-41. PubMed ID: 21399583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective efficacy afforded by live Pasteurella multocida vaccines in chickens is independent of lipopolysaccharide outer core structure.
    Harper M; John M; Edmunds M; Wright A; Ford M; Turni C; Blackall PJ; Cox A; Adler B; Boyce JD
    Vaccine; 2016 Mar; 34(14):1696-703. PubMed ID: 26892738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of iron-regulated outer membrane proteins of Pasteurella multocida B:2 in mice model.
    Kharb S; Charan S
    Indian J Exp Biol; 2010 Dec; 48(12):1181-7. PubMed ID: 21250599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidate vaccine antigens and genes in Pasteurella multocida.
    Adler B; Bulach D; Chung J; Doughty S; Hunt M; Rajakumar K; Serrano M; van Zanden A; Zhang Y; Ruffolo C
    J Biotechnol; 1999 Aug; 73(2-3):83-90. PubMed ID: 10486918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opsonic monoclonal antibodies against lipopolysaccharide (LPS) antigens of Pasteurella multocida and the role of LPS in immunity.
    Ramdani ; Adler B
    Vet Microbiol; 1991 Feb; 26(4):335-47. PubMed ID: 1709544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-protection factor(s) of Pasteurella multocida: passive immunization of turkeys against fowl cholera caused by different serotypes.
    Rimler RB
    Avian Dis; 1987; 31(4):884-7. PubMed ID: 3442539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the abilities of Salmonella typhimurium rpoS, aroA and rpoS aroA strains to elicit humoral immune responses in BALB/c mice and to cause lethal infection in athymic BALB/c mice.
    Coynault C; Norel F
    Microb Pathog; 1999 Jun; 26(6):299-305. PubMed ID: 10343058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary arginine supplementation enhances immune responses to inactivated Pasteurella multocida vaccination in mice.
    Ren W; Zou L; Li N; Wang Y; Liu G; Peng Y; Ding J; Cai L; Yin Y; Wu G
    Br J Nutr; 2013 Mar; 109(5):867-72. PubMed ID: 22809580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.